Evidence map›Paper›PMID 42072690›Full record

ArticleBiomolecules2026

Predominance of Biliverdin over Bilirubin in Human Seminal Plasma.

Nina Hojnik, Paola Sist, Sabina Passamonti, Borut Kovačič, Federica Tramer

Abstract read
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nina HojnikDepartment of Reproductive Medicine and Gynaecologic Endocrinology, Clinic for Gynecology and Perinatology, University Medical Centre Maribor, 2000 Maribor, Slovenia.ORCID 0000-0003-4206-4419
Paola SistDepartment of Life Sciences, University of Trieste, 34127 Trieste, Italy.ORCID 0000-0003-1626-5081
Sabina PassamontiDepartment of Life Sciences, University of Trieste, 34127 Trieste, Italy.ORCID 0000-0001-7876-4666
Borut KovačičDepartment of Reproductive Medicine and Gynaecologic Endocrinology, Clinic for Gynecology and Perinatology, University Medical Centre Maribor, 2000 Maribor, Slovenia.ORCID 0000-0003-3911-2408
Federica TramerDepartment of Life Sciences, University of Trieste, 34127 Trieste, Italy.ORCID 0000-0003-4286-0191

Funding

European Union via NextGenerationEU (iNEST-Interconnected Nord-Est Innovation Ecosystem) ID ECS0000004-CUP J43C22000320006Internal research project grant of University Medical Centre Maribor IRP-2021/01-23Slovenian Research and Innovation Agency (ARIS) P3-0327
6 · The paper itself

Abstract

Biliverdin (BV) and bilirubin (BR) are established endogenous antioxidants and immune modulators in other organ systems; however, their roles in the male genital tract remain undefined. The aim of this study was to quantify both bile pigments in human seminal plasma using a fluorescent protein biosensor and to examine their associations with basic semen parameters. We analyzed forty-two semen samples from men undergoing infertility evaluation. Biliverdin predominated over bilirubin in 88.1% of samples. Biliverdin concentration ranged from 51.8 to 611.2 nM, whereas bilirubin ranged from 19.7 to 240.7 nM. The mean total amounts per ejaculate were 1054 pmol for biliverdin and 280 pmol for bilirubin. The total amount of bilirubin in the ejaculate was positively correlated with total sperm count (Rs = 0.47;

Indexed as

BilirubinBiliverdineSemenAdultHumansMaleSperm CountBilirubinBiliverdinebilirubinbiliverdinbiosensorfluorometric analysisheme metabolismmale infertilitysemenUnaG

Identifiers

PMID42072690
PMCPMC13113757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.